Tg Therapeutics reported $53.2M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US USD 15.69B 1.36B
Ardelyx ARDX:US USD 65.6M 13.65M
Arrowhead Research ARWR:US USD 122.01M 16.84M
Bayer BAYN:GR EUR 35.08B 1.91B
Biogen BIIB:US USD 3.27B 653.6M
Corcept Therapeutics CORT:US USD 72.49M 19.42M
Curis CRIS:US USD 10.01M 3.73M
Dynavax Technologies DVAX:US USD 150.07M 94.01M
Gilead Sciences GILD:US USD 11.24B 814M
Infinity Pharmaceuticals INFI:US USD 14.2M 139K
Intercept Pharmaceuticals ICPT:US USD 230.08M 8.49M
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Novartis NOVN:VX USD 28.66B 496M
Novavax NVAX:US USD 2.46B 791.98M
Ptc Therapeutics PTCT:US USD 406.24M 13.84M
Puma Biotechnology PBYI:US USD 77.48M 17.5M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Roche Holding ROG:VX 27.24B 170M
Spectrum Pharmaceuticals SPPI:US USD 49.62M 8.58M
Tg Therapeutics TGTX:US USD 53.2M 16.75M
Verastem VSTM:US USD 21.66M 210K
Vertex Pharmaceuticals VRTX:US USD 2.43B 178.7M
Ziopharm Oncology ZIOP:US USD 24.17M 8.7M